Investing.com - GlaxoSmithKline reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
GlaxoSmithKline announced earnings per share of £0.328 on revenue of £9.78B. Analysts polled by Investing.com anticipated EPS of £0.2902 on revenue of £8.95B.
GlaxoSmithKline shares are up 10.77% from the beginning of the year and are trading at £1,779.60 , down-from-52-week-high.They are outperforming the TR UK 50 which is up 3.36% from the start of the year.
GlaxoSmithKline shares gained 1.43% in intra-day trade following the report.
GlaxoSmithKline follows other major Healthcare sector earnings this month
GlaxoSmithKline's report follows an earnings missed by Oxford BioMedica on Wednesday, April 20, 2022, who reported EPS of £0.01 on revenue of £61.55M, compared to forecasts EPS of £7.80 on revenue of £77.28M.
EKF Diagnostics had missed expectations on Tuesday, March 29, 2022 with first quarter EPS of £0.01 on revenue of £43.28M, compared to forecast for EPS of £2.19 on revenue of £42.45M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar